AMGN - Amgen Inc.

Price: -- -- | CONSENSUS: Buy DETAILS | PRICE TARGET: $361.88 DETAILS

Stock News

2 Dividend Stocks to Buy and Hold For 10 Years

These drugmakers can perform well despite competition and patent cliffs facing them. Both have excellent dividend programs and have increased their payouts at a good clip.

Jan 19, 2026 01:58 PM • fool.com

Courier Capital LLC Lowers Stake in Amgen Inc. $AMGN

Courier Capital LLC lessened its stake in shares of Amgen Inc. (NASDAQ: AMGN) by 15.9% during the undefined quarter, according to its most recent filing with the Securities and Exchange...

Jan 19, 2026 05:02 AM • defenseworld.net

Amgen's Weight-Loss Drug Shows Promise With Less Frequent Dosing

Amgen reported early Phase 2 data suggesting patients kept weight off with less frequent dosing, a potential differentiator from Eli Lilly and Novo Nordisk.

Jan 15, 2026 04:40 PM • barrons.com

Amgen (AMGN) Advances While Market Declines: Some Information for Investors

In the latest trading session, Amgen (AMGN) closed at $328.97, marking a +1.44% move from the previous day.

Jan 14, 2026 06:51 PM • zacks.com

Amgen Reports MariTide Weight Loss Holds Up With Fewer Doses

At a J.P. Morgan Healthcare Conference on Monday, Amgen Inc. (NASDAQ: AMGN) CEO Robert Bradway shared findings from part 2 of the Phase 2 Study of MariTide, its investigational obesity treatment.

Jan 14, 2026 12:36 PM • benzinga.com

Amgen CEO Bob Bradway goes one-on-one with Jim Cramer

Amgen CEO Bob Bradway joins 'Mad Money' host Jim Cramer to talk its rare disease business, its weight-loss drug offering, what is in Amgen's pipeline, and more.

Jan 13, 2026 07:55 PM • youtube.com

Amgen CEO: There are a bunch of ways to win for patients when it comes to weight loss

Amgen CEO Bob Bradway joins 'Mad Money' host Jim Cramer to talk its rare disease business, its weight-loss drug offering, what is in Amgen's pipeline, and more.

Jan 13, 2026 07:51 PM • youtube.com

Ro partners with Amgen to study barriers to obesity care, GLP-1 access

U.S. telehealth firm Ro said on Tuesday it has entered a research collaboration with drugmaker Amgen to examine challenges patients and providers face in accessing obesity treatments, including...

Jan 13, 2026 10:22 AM • reuters.com

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

Jan 13, 2026 09:55 AM • zacks.com

GRIMES & Co WEALTH MANAGEMENT LLC Trims Position in Amgen Inc. $AMGN

GRIMES and Co WEALTH MANAGEMENT LLC decreased its holdings in Amgen Inc. (NASDAQ: AMGN) by 5.9% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange...

Jan 13, 2026 06:10 AM • defenseworld.net

Amgen Inc. (AMGN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 12, 2026 09:16 PM • seekingalpha.com

Amgen says MariTide helped trial patients maintain weight loss

An extension study of Amgen's experimental obesity drug MariTide found that it helped people maintain weight loss while a second mid-stage trial in diabetes patients showed that it lowered their...

Jan 12, 2026 07:42 PM • reuters.com

Amgen to announce data on obesity drug MariTide at healthcare conference

Amgen's research chief said the company is very confident about its experimental obesity drug MariTide, as it prepares on Monday to unveil results from a mid-stage trial extension designed to show...

Jan 12, 2026 06:46 PM • reuters.com

Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know

Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Jan 12, 2026 10:01 AM • zacks.com

The 2026 Dogs Of The Dow: 10 High-Yield Blue Chips

The Dow Jones Industrial Average itself yields modestly, but the Dogs of the Dow 2026 pack more dividend bite. The index's top payers dish up to 6.8%.

Jan 11, 2026 07:40 AM • forbes.com

January Dogs Of The Dow: One Ideal 'Safer' Dividend Buy

Verizon stands out as the only Dow stock meeting the 'dogcatcher' ideal: annual dividends from $1K invested exceed its single share price. Analyst projections suggest the top ten Dow Dogs could...

Jan 10, 2026 09:52 AM • seekingalpha.com

Amgen Inc. $AMGN Shares Bought by Ferguson Wellman Capital Management Inc.

Ferguson Wellman Capital Management Inc. grew its position in shares of Amgen Inc. (NASDAQ: AMGN) by 2.7% during the undefined quarter, according to the company in its most recent disclosure with...

Jan 09, 2026 04:33 AM • defenseworld.net

Amgen (AMGN) Stock Falls Amid Market Uptick: What Investors Need to Know

In the closing of the recent trading day, Amgen (AMGN) stood at $330.05, denoting a -3.39% move from the preceding trading day.

Jan 08, 2026 06:51 PM • zacks.com

Can These Dividend Stocks Beat the Market Again in 2026?

Building on a strong 2025, CVS Health's outlook for 2026 and beyond looks promising. Amgen is developing newer drug products that will address a recent patent cliff.

Jan 08, 2026 08:37 AM • fool.com

CoreCap Advisors LLC Lowers Position in Amgen Inc. $AMGN

CoreCap Advisors LLC reduced its position in shares of Amgen Inc. (NASDAQ: AMGN) by 26.2% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange...

Jan 08, 2026 04:55 AM • defenseworld.net